Skip to content

Dogwood Therapeutics DWTX Deferred Tax Assets

Deferred Tax Assets at other companies

Eli Lilly logo
Eli LillyLLY
$11.35B+32.4%
Pfizer logo
PfizerPFE
-$12M-101%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$113.57M+23.9%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's deferred tax assets?
Dogwood Therapeutics (DWTX) reported deferred tax assets of $11.91M in Q1 2026.
How has Dogwood Therapeutics's deferred tax assets changed year-over-year?
Dogwood Therapeutics's deferred tax assets increased by 3.4% year-over-year, from $11.52M to $11.91M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.